Project Leader: Dr. Oliwia Kowalczyk
The MediComm project addresses critical needs in health communication for cancer prevention, particularly within groups with diverse cognitive profiles. Research indicates significant communication barriers that lead to diagnostic delays and insufficient recognition of early symptoms in high-risk populations, often resulting in cancer being diagnosed only at advanced stages.
The primary aim of the project is to develop empirically validated multimodal communication tools, based on the integration of health behavioral theories with advanced methods of multimodal semiotics and cognitive accessibility. The research will involve a systematic analysis of mechanisms underlying the perception of health information, conducted through a sequential exploratory mixed-methods study, incorporating innovative research protocols that account for neurodivergent populations.
The innovation of the project lies in the implementation of an integrated analytical methodology, combining neurolinguistic methods, attentional process analysis techniques, and participatory research within a unified research protocol. The application of advanced analytical algorithms will enable the construction of predictive communication models with proven clinical effectiveness, adaptable to diverse healthcare contexts.
A strategic component of the project will be the clinical validation of the developed tools and the development of prototype digital solutions to support cognitive accessibility of preventive materials, in accordance with international ethical and methodological standards. MediComm represents a pioneering approach compared to conventional medical communication strategies, with transformative potential for clinical oncology practice and the possibility of scaling solutions across healthcare systems.